Armstrong Advisory Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Armstrong Advisory Group's AZN Position: Q3 2026 in Review
Armstrong Advisory Group reduced its AstraZeneca (AZN) stake by 17% in Q3 2026, selling an estimated $19.8K and leaving 596 shares worth $96.2K. The position accounts for 0.01% of the portfolio, ranked #348.
Armstrong Advisory Group first reported a position in AZN in Q4 2022 and has held it in 16 quarters since. The position peaked at $141K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Armstrong Advisory Group held 596 shares of AstraZeneca worth $96.2K as of Q3 2026.
- Armstrong Advisory Group sold 119 AstraZeneca shares in Q3 2026, an estimated $19.8K.
- AstraZeneca made up 0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #348 holding.
- Armstrong Advisory Group first reported a position in AstraZeneca in Q4 2022 and has held it in 16 quarters since.
- Armstrong Advisory Group's AstraZeneca position peaked at $141K in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.